Alterity Therapeutics Lim... (ATHE)
NASDAQ: ATHE
· Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Aug 15, 2025, 3:59 PM
5.20
0.58%
After-hours: Aug 15, 2025, 06:47 PM EDT
Alterity Therapeutics Income Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Revenue | 802.96K | 802.96K | 2.12M | 1.06M | 1.9M | 950.36K | 1.53M | 765.25K | 2.39M | 2.76M | 2.36M | 2.46M | 1.88M |
Cost of Revenue | 31.8K | 31.8K | 73.61K | 58.67K | 73.92K | 48.48K | 52.27K | 62.52K | 50K | 22.68K | 31.54K | 39.74K | 35.63K |
Gross Profit | 771.16K | 771.16K | 2.04M | 1M | 1.83M | 901.88K | 1.48M | 702.73K | 2.34M | 2.74M | 2.33M | 2.42M | 1.85M |
Operating Income | -3.74M | -3.74M | -15.1M | -6.49M | -8.52M | -3.31M | -7.77M | -3.12M | -10.75M | -10.46M | -10.16M | -9.88M | -9.64M |
Interest Income | n/a | n/a | 150.02K | n/a | 118.4K | n/a | 5.06K | n/a | 11.38K | 1.15K | 1.35K | 14.12K | 6.55K |
Pretax Income | -3.59M | -3.59M | -14.69M | -6.29M | -8.41M | -3.25M | -7.3M | -2.89M | -10.31M | -8.73M | -8.72M | -8.99M | -10.45M |
Net Income | -3.59M | -3.59M | -12.62M | -6.31M | -6.51M | -3.25M | -5.77M | -2.89M | -8.03M | -6.26M | -6.58M | -6.75M | -8.56M |
Selling & General & Admin | 1.66M | 1.66M | 2.75M | 1.35M | 2.08M | 1.03M | 2.29M | 1.11M | 2.94M | 2.46M | 3.37M | 3.36M | 3.8M |
Research & Development | 2.86M | 2.86M | 12.28M | 6.14M | 6.36M | 3.18M | 5.43M | 2.72M | 7.76M | 7.98M | 6.76M | 6.48M | 5.81M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.51M | 4.51M | 14.98M | 7.49M | 8.45M | 4.21M | 7.72M | 3.82M | 10.7M | 10.44M | 10.13M | 9.84M | 9.6M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 168.1K | 168.1K | -5K | -2.5K | 18.38K | n/a | 7.11K | 7.11K | 18.64K | 24.44K | 15.23K | -22.43K | 33.33K |
Cost & Expenses | 4.55M | 4.55M | 15.1M | 7.55M | 8.52M | 4.26M | 7.77M | 3.89M | 10.75M | 10.46M | 10.16M | 9.88M | 9.64M |
Income Tax Expense | n/a | n/a | -2.07M | 23.04K | -1.9M | n/a | -1.53M | 280.00 | -2.28M | -2.47M | -2.13M | -2.24M | -1.88M |
Shares Outstanding (Basic) | 8.54M | 8.54M | 10.51M | 8M | 4.17M | 4.17M | 4.07M | 4.02M | 4.02M | 4.01M | 4.01M | 3.47M | 2.21M |
Shares Outstanding (Diluted) | 8.86M | 8.86M | 10.51M | 7.99M | 4.17M | 4.17M | 4.07M | 4.07M | 4.02M | 4.01M | 4.01M | 3.47M | 2.21M |
EPS (Basic) | -0.42 | -0.42 | -1.2 | -0.78 | -1.56 | -0.78 | -1.44 | -0.72 | -1.98 | -1.56 | -1.62 | -1.92 | -3.9 |
EPS (Diluted) | -0.42 | -0.42 | -1.2 | -0.78 | -1.56 | -0.78 | -1.44 | -0.72 | -1.98 | -1.56 | -1.62 | -1.92 | -3.9 |
EBITDA | -3.76M | -3.76M | -14.62M | -6.48M | -8.33M | -3.3M | -7.25M | -3.11M | -10.26M | -8.71M | -8.69M | -8.95M | -10.41M |
EBIT | -3.77M | -3.77M | -14.69M | -6.49M | -8.41M | -3.31M | -7.3M | -3.12M | -10.31M | -8.73M | -8.72M | -8.99M | -10.45M |
Depreciation & Amortization | 8.43K | 8.43K | 73.61K | 8.49K | 73.92K | 9.18K | 52.27K | 9.09K | 50K | 22.68K | 31.54K | 39.74K | 35.63K |